LEAMINGTON, Ontario, June 29, 2022 (GLOBE NEWSWIRE) Tilray Brands, Inc. ("Tilray" or the "Company") (Nasdaq: TLRY; TSX: TLRY), a leading global cannabis-lifestyle and consumer packaged goods company
Tilray® Selected by French National Agency to Supply GMP-Certified Medical Cannabis Products in France
Tilray® Selected by French National Agency to Supply GMP-Certified Medical Cannabis Products in France Tilray, Inc. (NASDAQ: TLRY), a global pioneer in cannabis production, research, cultivation, and distribution, announced that it has been selected by the French National Agency for the Safety of Medicines and Health Products (ANSM) to supply Good Manufacturing Processes (GMP) certified medical cannabis products for experimentation in France. Tilray will supply GMP-produced medical cannabis products to serve patients in need for the duration of the French experiment (18-24 months), due to begin in the first quarter of 2021.